Market Research Logo

Global Bipolar Disorder Therapeutic Market 2019-2023

Global Bipolar Disorder Therapeutic Market 2019-2023

About Bipolar Disorder

Bipolar disorder is also known as manic depression that causes extreme shifts in mood, energy, and activity levels. Elevated mood swings are called mania or hypomania, which differs based on the severity and presence of psychosis. Bipolar disorder is a long-lasting condition that can be categorized into bipolar I, bipolar II, and cyclothymia. This condition can be managed with a regular treatment. Insomnia, weight gain or loss, behavioral changes, and psychological imbalances are some of the symptoms witnessed in individuals with bipolar disorder.

Technavio’s analysts forecast the Global Bipolar Disorder Therapeutics Market to grow at a CAGR of 2.38% during the period 2019-2023.

Covered in this report

The report covers the present scenario and the growth prospects of the bipolar disorder therapeutics market. To calculate the market size, the report considers the revenue generated from the application of bipolar disorder therapeutics across the globe.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, bipolar disorder therapeutics market 2019-2023, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Allergan
  • AstraZeneca
  • Eli Lilly
  • GlaxoSmithKline
  • Johnson & Johnson
Market driver
  • Growing prevalence of mental health disorders (MHDs) across the globe.
  • For a full, detailed list, view our report
Market challenge
  • Lack of adequate diagnosis process
  • For a full, detailed list, view our report
Market trend
  • Growing number of strategic alliances
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2023 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


PRESS RELEASE

Technavio Announces the Publication of its Research Report - Global Bipolar Disorder Therapeutics Market 2019-2023

Technavio recognizes the following companies as the key players in the global bipolar disorder therapeutics market: Allergan, AstraZeneca, Eli Lilly, GlaxoSmithKline, and Johnson & Johnson.

Commenting on the report, an analyst from Technavio’s team said: “One trend affecting this market is the growing number of strategic alliances between vendors. Most of the vendors are focused on entering into strategic alliances to develop the most effective treatment for bipolar treatment and expand their product portfolio.”

According to the report, one driver influencing this market is the growing prevalence of mental health disorders (MHDs) across the globe. The rising incidences of these MHDs is resulting in a great need for the development of the most effective treatment for bipolar disorder.

Further, the report states that one challenge affecting this market is the lack of adequate diagnosis process. The lack of a proper technical diagnostic process is a key challenge in the global bipolar disorder therapeutics market.

Companies Mentioned

Allergan
AstraZeneca
Eli Lilly
GlaxoSmithKline
Johnson & Johnson

  • Executive summary
  • Scope of the report
  • Market landscape
    • Market ecosystem
      • Table Global CNS therapeutics market
      • Table Segments of global cns therapeutics market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Market size and forecast 2018-2023 ($ mn)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Market segmentation by product
    • Table Product - Market share 2018-2023 (%)
    • Comparison by product
      • Table Comparison by product
    • Antipsychotics - Market size and forecast 2018-2023
      • Table Antipsychotics - Market size and forecast 2018-2023 ($ millions)
      • Table Antipsychotics - Year-over-year growth 2019-2023 (%)
    • Anticonvulsants - Market size and forecast 2018-2023
      • Table Anticonvulsants - Market size and forecast 2018-2023 ($ millions)
      • Table Anticonvulsants - Year-over-year growth 2019-2023 (%)
    • Traditional mood stabilizers - Market size and forecast 2018-2023
      • Table Traditional mood stabilizers - Market size and forecast 2018-2023 ($ millions)
      • Table Traditional mood stabilizers - Year-over-year growth 2019-2023 (%)
    • Others - Market size and forecast 2018-2023
      • Table Others - Market size and forecast 2018-2023 ($ millions)
      • Table Others - Year-over-year growth 2019-2023 (%)
    • Market opportunity by product
      • Table Market opportunity by product
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • Americas - Market size and forecast 2018-2023
      • Table Americas - Market size and forecast 2018-2023 ($ millions)
      • Table Americas - Year-over-year growth 2019-2023 (%)
    • EMEA - Market size and forecast 2018-2023
      • Table EMEA - Market size and forecast 2018-2023 ($ millions)
      • Table EMEA - Year-over-year growth 2019-2023 (%)
    • APAC - Market size and forecast 2018-2023
      • Table APAC - Market size and forecast 2018-2023 ($ millions)
      • Table APAC - Year-over-year growth 2019-2023 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Impact of drivers and challenges
  • Market trends
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • ALLERGAN
      • Table ALLERGAN - Vendor overview
      • Table ALLERGAN - Business segments
      • Table ALLERGAN - Organizational developments
      • Table ALLERGAN - Geographic focus
      • Table ALLERGAN - Segment focus
      • Table ALLERGAN - Key offerings
    • AstraZeneca
      • Table AstraZeneca - Vendor overview
      • Table AstraZeneca - Business segments
      • Table AstraZeneca - Organizational developments
      • Table AstraZeneca - Geographic focus
      • Table AstraZeneca - Segment focus
      • Table AstraZeneca - Key offerings
    • Eli Lilly
      • Table Eli Lilly - Vendor overview
      • Table Eli Lilly - Business segments
      • Table Eli Lilly - Organizational developments
      • Table Eli Lilly - Geographic focus
      • Table Eli Lilly - Segment focus
      • Table Eli Lilly - Key offerings
    • GlaxoSmithKline
      • Table GlaxoSmithKline - Vendor overview
      • Table GlaxoSmithKline - Business segments
      • Table GlaxoSmithKline - Organizational developments
      • Table GlaxoSmithKline - Geographic focus
      • Table GlaxoSmithKline - Segment focus
      • Table GlaxoSmithKline - Key offerings
    • Johnson & Johnson
      • Table Johnson & Johnson - Vendor overview
      • Table Johnson & Johnson - Business segments
      • Table Johnson & Johnson - Organizational developments
      • Table Johnson & Johnson - Geographic focus
      • Table Johnson & Johnson - Segment focus
      • Table Johnson & Johnson - Key offerings
  • Appendix
    • Research methodology
      • Table Validation techniques employed for market sizing
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report